Publikationen in Zusammenarbeit mit Forschern von Charles University in Prague (45)

2024

  1. Clinical presentation of psychotic experiences in patients with common mental disorders attending the UK primary care improving access to psychological therapies (IAPT) Programme

    Journal of Affective Disorders, Vol. 344, pp. 233-241

  2. Non-apoptotic FAS signaling controls mTOR activation and extrafollicular maturation in human B cells

    Science Immunology, Vol. 9, Núm. 91

2023

  1. Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal Gammopathies

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 16, pp. 3019-3031

  2. Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation

    Haematologica

  3. Labetalol and soluble endoglin aggravate bile acid retention in mice with ethinylestradiol-induced cholestasis

    Frontiers in Pharmacology, Vol. 14

2021

  1. Bridging the divide between biomedical and psychosocial approaches in dementia research: the 2019 INTERDEM manifesto

    Aging and Mental Health, Vol. 25, Núm. 2, pp. 206-212

  2. Employability With Mental Illness: The Perspectives of Employers and Mental Health Workers

    Rehabilitation Counseling Bulletin, Vol. 64, Núm. 4, pp. 195-207

  3. High soluble endoglin levels affect aortic vascular function during mice aging

    Journal of Cardiovascular Development and Disease, Vol. 8, Núm. 12

  4. Psychosocial care in dementia in European higher education: Evidence from the SiDECar (“Skills in DEmentia Care”) project

    Nurse Education Today, Vol. 103

  5. The integration of psychosocial care into national dementia strategies across europe: Evidence from the skills in dementia care (SiDECar) project

    International Journal of Environmental Research and Public Health, Vol. 18, Núm. 7

  6. Total body irradiation + fludarabine compared to busulfan + fludarabine as “reduced-toxicity conditioning” for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation in first complete remission: a study by the Acute Leukemia Working Party of the EBMT

    Bone Marrow Transplantation, Vol. 56, Núm. 2, pp. 481-491

2020

  1. Long term effects of soluble endoglin and mild hypercholesterolemia in mice hearts

    PLoS ONE, Vol. 15, Núm. 5

  2. Soluble endoglin as a potential biomarker of nonalcoholic steatohepatitis (Nash) development, participating in aggravation of nash-related changes in mouse liver

    International Journal of Molecular Sciences, Vol. 21, Núm. 23, pp. 1-19

2019

  1. Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

    The Lancet, Vol. 393, Núm. 10168, pp. 229-240

  2. Comparative genomics of the major parasitic worms

    Nature Genetics, Vol. 51, Núm. 1, pp. 163-174

  3. Defects in memory B-cell and plasma cell subsets expressing different immunoglobulin-subclasses in patients with CVID and immunoglobulin subclass deficiencies

    Journal of Allergy and Clinical Immunology, Vol. 144, Núm. 3, pp. 809-824

  4. Differential expression of CD73, CD86 and CD304 in normal vs. leukemic B-cell precursors and their utility as stable minimal residual disease markers in childhood B-cell precursor acute lymphoblastic leukemia

    Journal of Immunological Methods, Vol. 475

  5. Fluorochrome choices for multi-color flow cytometry

    Journal of Immunological Methods, Vol. 475

  6. Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)

    European Journal of Immunology, Vol. 49, Núm. 10, pp. 1457-1973

  7. High soluble endoglin levels regulate cholesterol homeostasis and bile acids turnover in the liver of transgenic mice

    Life Sciences, Vol. 232